MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 168 filers reported holding MANNKIND CORP in Q1 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $866,000 | +18.6% | 1,360,788 | +10.4% | 0.00% | – |
Q3 2016 | $730,000 | -14.1% | 1,232,574 | +68.3% | 0.00% | – |
Q2 2016 | $850,000 | -27.9% | 732,574 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $1,179,000 | +11.0% | 732,574 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,062,000 | -83.9% | 732,574 | -64.4% | 0.00% | -66.7% |
Q3 2015 | $6,613,000 | -43.6% | 2,060,008 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $11,721,000 | +9.4% | 2,060,008 | 0.0% | 0.01% | +20.0% |
Q1 2015 | $10,712,000 | -2.2% | 2,060,008 | -1.9% | 0.01% | -16.7% |
Q4 2014 | $10,955,000 | -18.7% | 2,100,710 | -7.8% | 0.01% | -14.3% |
Q3 2014 | $13,469,000 | -73.4% | 2,278,963 | -50.6% | 0.01% | -50.0% |
Q2 2014 | $50,722,000 | +678.9% | 4,615,416 | +185.0% | 0.01% | +250.0% |
Q1 2014 | $6,512,000 | -22.8% | 1,619,708 | 0.0% | 0.00% | -20.0% |
Q4 2013 | $8,439,000 | -11.1% | 1,619,708 | -2.8% | 0.01% | -16.7% |
Q3 2013 | $9,496,000 | +26.5% | 1,666,102 | +44.3% | 0.01% | +20.0% |
Q2 2013 | $7,504,000 | +172.6% | 1,154,469 | +42.2% | 0.01% | +150.0% |
Q1 2013 | $2,753,000 | +79.9% | 811,989 | +52.9% | 0.00% | +100.0% |
Q3 2012 | $1,530,000 | +21.0% | 531,090 | 0.0% | 0.00% | 0.0% |
Q2 2012 | $1,264,000 | – | 531,090 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AYM CAPITAL, LLC | 1,305,000 | $7,713,000 | 5.61% |
Greywolf Capital Management LP | 6,206,570 | $36,681,000 | 4.08% |
AYM CAPITAL, LLC | 692,300 | $4,092,000 | 2.98% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 1,412,600 | $8,348,000 | 2.26% |
B. Riley Wealth Advisors, Inc. | 1,238,880 | $7,322,000 | 1.11% |
ZEKE LP /PA | 50,000 | $295,000 | 1.06% |
Old West Investment Management, LLC | 266,566 | $1,575,000 | 0.99% |
Cohen Capital Management, Inc. | 500,000 | $2,955,000 | 0.79% |
Tourbillon Capital Partners, L.P. | 3,250,000 | $19,208,000 | 0.70% |
Adamant Biomedical Investments AG | 300,000 | $1,773,000 | 0.44% |